热门资讯> 正文
Lexeo Therapeutics通过私募融资8000万美元
2025-05-28 01:56
- Lexeo Therapeutics (NASDAQ:LXEO) has secured approximately $80M through a private placement with institutional and healthcare-focused investors.
- As part of the deal, Lexeo will sell 20.8M shares of common stock or pre-funded warrants for 7M shares.
- Each share comes with a warrant to purchase half a share of common stock, and the purchase price per share and accompanying warrant is $2.88.
- The funding, along with Lexeo’s existing cash, cash equivalents, and marketable securities, is expected to support the company’s operations and capital needs into 2028.
More on Lexeo Therapeutics
- Lexeo: Alignment Gained With FDA Brings Further LX2006 Program Advancement
- Top 10 Russell 2000 weekly gainers and losers as Wall Street crashes
- Seeking Alpha’s Quant Rating on Lexeo Therapeutics
- Historical earnings data for Lexeo Therapeutics
- Financial information for Lexeo Therapeutics
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
